These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 21170652

  • 1. [Early treatment of exudative age-related macular degeneration with ranibizumab (Lucentis®): the key to success].
    Matthé E, Sandner D.
    Ophthalmologe; 2011 Mar; 108(3):237-43. PubMed ID: 21170652
    [Abstract] [Full Text] [Related]

  • 2. [Monotherapy of exudative age-related macular degeneration with ranibizumab in patients at cardiovascular risk. Advantages of ranibizumab compared to a combination with pegaptanib].
    Matthé E, Sandner D.
    Ophthalmologe; 2011 Apr; 108(4):337-41. PubMed ID: 21181168
    [Abstract] [Full Text] [Related]

  • 3. Retinal pigment epithelial tears after intravitreal bevacizumab injection for exudative age-related macular degeneration.
    Garg S, Brod R, Kim D, Lane RG, Maguire J, Fischer D.
    Clin Exp Ophthalmol; 2008 Apr; 36(3):252-6. PubMed ID: 18412594
    [Abstract] [Full Text] [Related]

  • 4. Comparison of two intravitreal ranibizumab treatment schedules for neovascular age-related macular degeneration.
    Gupta B, Adewoyin T, Patel SK, Sivaprasad S.
    Br J Ophthalmol; 2011 Mar; 95(3):386-90. PubMed ID: 20693484
    [Abstract] [Full Text] [Related]

  • 5. Long-term visual course after anti-VEGF therapy for exudative AMD in clinical practice evaluation of the German reinjection scheme.
    Heimes B, Lommatzsch A, Zeimer M, Gutfleisch M, Spital G, Dietzel M, Pauleikhoff D.
    Graefes Arch Clin Exp Ophthalmol; 2011 May; 249(5):639-44. PubMed ID: 20890777
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of injection frequency and visual acuity outcomes for ranibizumab monotherapy in exudative age-related macular degeneration.
    Dadgostar H, Ventura AA, Chung JY, Sharma S, Kaiser PK.
    Ophthalmology; 2009 Sep; 116(9):1740-7. PubMed ID: 19643484
    [Abstract] [Full Text] [Related]

  • 7. [Cost-utility analysis of ranibizumab (Lucentis) in neovascular macular degeneration].
    Neubauer AS, Holz FG, Schrader W, Back EI, Kühn T, Hirneiss C, Kampik A.
    Klin Monbl Augenheilkd; 2007 Sep; 224(9):727-32. PubMed ID: 17846963
    [Abstract] [Full Text] [Related]

  • 8. Comparison of intravitreal bevacizumab followed by ranibizumab for the treatment of neovascular age-related macular degeneration.
    Stepien KE, Rosenfeld PJ, Puliafito CA, Feuer W, Shi W, Al-Attar L, Dubovy SR, Murray TG, Davis JL, Lee WH, Schwartz SG, Smiddy WE, Berrocal AM, Flynn HW.
    Retina; 2009 Sep; 29(8):1067-73. PubMed ID: 19696701
    [Abstract] [Full Text] [Related]

  • 9. Intravitreal ranibizumab (Lucentis) in the treatment of retinal angiomatous proliferation (RAP).
    Konstantinidis L, Mameletzi E, Mantel I, Pournaras JA, Zografos L, Ambresin A.
    Graefes Arch Clin Exp Ophthalmol; 2009 Sep; 247(9):1165-71. PubMed ID: 19404661
    [Abstract] [Full Text] [Related]

  • 10. Comparative study of intravitreal bevacizumab (Avastin) versus ranibizumab (Lucentis) in the treatment of neovascular age-related macular degeneration.
    Landa G, Amde W, Doshi V, Ali A, McGevna L, Gentile RC, Muldoon TO, Walsh JB, Rosen RB.
    Ophthalmologica; 2009 Sep; 223(6):370-5. PubMed ID: 19590252
    [Abstract] [Full Text] [Related]

  • 11. Visual outcome of intravitreal ranibizumab for exudative age-related macular degeneration: timing and prognosis.
    Canan H, Sızmaz S, Altan-Yaycıoğlu R, Sarıtürk C, Yılmaz G.
    Clin Interv Aging; 2014 Sep; 9():141-5. PubMed ID: 24453484
    [Abstract] [Full Text] [Related]

  • 12. Ranibizumab for the treatment of neovascular age-related macular degeneration: a review.
    Kourlas H, Abrams P.
    Clin Ther; 2007 Sep; 29(9):1850-61. PubMed ID: 18035187
    [Abstract] [Full Text] [Related]

  • 13. [Retinal angiomatous proliferation with associated pigment epithelium detachment: anti-VEGF therapy].
    Lommatzsch A, Heimes B, Gutfleisch M, Spital G, Dietzel M, Pauleikhoff D.
    Ophthalmologe; 2011 Mar; 108(3):244-51. PubMed ID: 20571805
    [Abstract] [Full Text] [Related]

  • 14. Ranibizumab for exudative age-related macular degeneration in eyes previously treated with alternative vascular endothelial growth factor inhibitors.
    Ehlers JP, Spirn MJ, Shah CP, Fenton GL, Baker PS, Regillo CD, Ho AC.
    Ophthalmic Surg Lasers Imaging; 2010 Mar; 41(2):182-9. PubMed ID: 20307035
    [Abstract] [Full Text] [Related]

  • 15. Effects of ranibizumab in patients with subfoveal choroidal neovascularization attributable to age-related macular degeneration.
    Rothenbuehler SP, Waeber D, Brinkmann CK, Wolf S, Wolf-Schnurrbusch UE.
    Am J Ophthalmol; 2009 May; 147(5):831-7. PubMed ID: 19217019
    [Abstract] [Full Text] [Related]

  • 16. [Intravitreal ranibizumab for age-related macular degeneration].
    Sørensen TL, Kemp H.
    Ugeskr Laeger; 2010 May 31; 172(22):1685-9. PubMed ID: 20525469
    [Abstract] [Full Text] [Related]

  • 17. Ranibizumab and pegaptanib for the treatment of age-related macular degeneration: a systematic review and economic evaluation.
    Colquitt JL, Jones J, Tan SC, Takeda A, Clegg AJ, Price A.
    Health Technol Assess; 2008 May 31; 12(16):iii-iv, ix-201. PubMed ID: 18462575
    [Abstract] [Full Text] [Related]

  • 18. Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.
    Goff MJ, Johnson RN, McDonald HR, Ai E, Jumper JM, Fu A.
    Retina; 2007 May 31; 27(4):432-8. PubMed ID: 17420694
    [Abstract] [Full Text] [Related]

  • 19. Treatment of neovascular age-related macular degeneration with a variable ranibizumab dosing regimen and one-time reduced-fluence photodynamic therapy: the TORPEDO trial at 2 years.
    Spielberg L, Leys A.
    Graefes Arch Clin Exp Ophthalmol; 2010 Jul 31; 248(7):943-56. PubMed ID: 20204659
    [Abstract] [Full Text] [Related]

  • 20. Tolerability and efficacy of multiple escalating doses of ranibizumab (Lucentis) for neovascular age-related macular degeneration.
    Rosenfeld PJ, Heier JS, Hantsbarger G, Shams N.
    Ophthalmology; 2006 Apr 31; 113(4):623.e1. PubMed ID: 16581423
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.